Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma, Non-Hodgkin 1Hodgkin Disease 1HIV Infections 1

Interventions

Zidovudine 6tecogalan 4Vincristine 4Interferon alpha-2 4Doxorubicin 4Bleomycin 4sargramostim 3Specimen Handling 3Magnetic Resonance Spectroscopy 3interferon alfa-n1 2cabozantinib 2Nivolumab 2Cyclophosphamide 2Biopsy 2technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran 1pembrolizumab 1ibrutinib 1fludarabine 1efineptakin alfa 1axicabtagene ciloleucel 1Zalcitabine 1Vorinostat 1Tumor Necrosis Factor-alpha 1Transplantation Conditioning 1Taxes 1Sunitinib 1Polymerase Chain Reaction 1Pentoxifylline 1Paclitaxel 1O-(Chloroacetylcarbamoyl)fumagillol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × HIV Infections × Transplantation Conditioning × Clear all
NCT02378922 2018-12-27

Gene-Modified HIV-Protected Stem Cell Transplant in Treating Patients With HIV-Associated Lymphoma

Fred Hutchinson Cancer Center

Phase 1 Withdrawn
Lymphoid

Hodgkin Disease, Lymphoma, Non-Hodgkin, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡